National Cancer Institute (NCI) Grants

Open National Cancer Institute (NCI) grants

• NCI SBIR Phase IIB Bridge Award

  Up to $4.5Mopen

  NCI SBIR Phase IIB Bridge Award is sponsored by National Cancer Institute (NCI). Supports the next stage of development for federally funded SBIR Phas...

  cancer_researchbiomedical_researchhealth_disparitiescancerbiotech

• NCI Outstanding Investigator Award (R35)

  Up to $600Kopen

  NCI Outstanding Investigator Award (R35) is a grant from the National Cancer Institute (NCI) that supports investigators with outstanding cancer resea...

  cancer_researchbiomedical_researchhealth_disparitiescanceroncology

• Mechanisms that Impact Cancer Risk after Bariatric Surgery (R01 Clinical Trial Optional)

  Up to $500Kopen

  Mechanisms that Impact Cancer Risk after Bariatric Surgery (R01 Clinical Trial Optional) is sponsored by National Cancer Institute (NCI). Funds resear...

  cancer_researchpublic_healthclinical_researchcancer riskbariatric surgery

• National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)

  Up to $500Kopen

  National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required) is spo...

  cancer_researchclinical_researchprecision_medicinebiomedical_researchcancer

• Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed)

  Up to $275KDeadline: Jan 7, 2028open

  Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed) is sponsored by National Cancer Institute (NCI). This...

  biomedical_researchcancer_researchclinical_researchbioengineeringcancer detection

• Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)

  Up to $275Kopen

  Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed) is sponsored by Na...

  cancer_researchpublic_healthbiomedical_researchcancerepidemiology

• PA-25-253: Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)

  Up to $275Kopen

  PA-25-253: Exploratory Grants in Cancer Control (R21 Clinical Trial Optional) is sponsored by National Cancer Institute (NCI).

  cancer_researchpublic_healthhealth_disparitiesclinical_researchcancer control

• NCI Mentored Research Scientist Development Award (K01 - Independent Clinical Trial Required)

  Up to $150Kopen

  NCI Mentored Research Scientist Development Award (K01 - Independent Clinical Trial Required) is sponsored by National Cancer Institute (NCI). Provide...

  cancer_researchpublic_healthbiomedical_researchhealth_disparitiescancer

• Development of Digital Biomarkers and Endpoints for Clinical Cancer Care

  Deadline: Sep 5, 2026open

  Development of Digital Biomarkers and Endpoints for Clinical Cancer Care is sponsored by National Cancer Institute (NCI). Supports the development of ...

  cancer_researchclinical_researchbiomedical_researchai_healthcaredata_science

• Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (PAR-25-095)

  Deadline: Sep 7, 2026open

  Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01) is a grant from the National Cancer Institute ...

  cancer_researchclinical_researchprecision_medicinebiomedical_researchcancer risk

• NCI Community Oncology Research Program (NCORP) Research Bases

  Deadline: Sep 18, 2026open

  NCI Community Oncology Research Program (NCORP) Research Bases is sponsored by National Cancer Institute (NCI). This program is designed to enhance th...

  cancer_researchclinical_researchpublic_healthcanceroncology

• NCI Community Oncology Research Program (NCORP) Community Sites (UG1 Clinical Trial Not Allowed)

  Deadline: Sep 18, 2026open

  NCI Community Oncology Research Program (NCORP) Community Sites (UG1 Clinical Trial Not Allowed) is sponsored by National Cancer Institute (NCI). This...

  cancer_researchclinical_researchpublic_healthhealth_disparitiescancer control

• Metastasis Research Network (U54 Clinical Trial Not Allowed)

  Deadline: Sep 26, 2026open

  Metastasis Research Network (U54 Clinical Trial Not Allowed) is sponsored by National Cancer Institute (NCI). Supports the establishment of a network ...

  cancer_researchclinical_researchbiomedical_researchmetastasiscancer

• Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional)

  Deadline: Oct 5, 2026open

  This NIH R01 opportunity (PAR-25-221), jointly supported by NCI and NIAAA, funds research on population-level strategies to reduce cancer risk attribu...

  cancer_researchpublic_healthalcoholcancerpublic_health

• Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk (NCI)

  Deadline: Oct 5, 2026open

  Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk (NCI) is sponsored by National Cancer Institute (NCI). This funding oppor...

  cancer_researchenvironmental_justicebiomedical_researchcancer etiologybiomarkers

• Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01 Clinical Trial Not Allowed)

  Deadline: Oct 5, 2026open

  Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01 Clinical Trial Not Allowed) is sponsored by National Ca...

  cancer_researchbiomedical_researchclinical_researchprecision_medicinemammalian models

• Assay Validation of High Quality Markers for Clinical Studies in Cancer (PAR-25-074)

  Deadline: Oct 14, 2026open

  Assay Validation of High Quality Markers for Clinical Studies in Cancer (PAR-25-074) is sponsored by National Cancer Institute (NCI). This UH2/UH3 gra...

  cancer_researchclinical_researchbiomedical_researchprecision_medicineassay validation

• Assay Validation of High Quality Markers for Clinical Studies in Cancer (Clinical Trial Not Allowed) (PAR-25-074)

  Deadline: Oct 15, 2026open

  Assay Validation of High Quality Markers for Clinical Studies in Cancer (Clinical Trial Not Allowed) (PAR-25-074) is sponsored by National Cancer Inst...

  cancer_researchclinical_researchbiomedical_researchprecision_medicinecancer biomarkers

• Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (Clinical Trial Not Allowed) (PAR-24-304)

  Deadline: Oct 15, 2026open

  Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (Clinical Trial Not Allowed) (PAR-24-304) is ...

  cancer_researchbiomedical_researchprecision_medicinebiomarker validationassay development

• NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (PAR-23-286)

  Deadline: Oct 15, 2026open

  NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (PAR-23-286) is sponsored by National Cancer Institute (NCI). This K99/R00 ...

  cancer_researchbiomedical_researchclinical_researchpostdoctoral fellowshipearly career researcher

What National Cancer Institute (NCI) funds

Top program areas based on GrantMind's analysis of recent National Cancer Institute (NCI) awards:

How to apply for National Cancer Institute (NCI) grants

Most National Cancer Institute (NCI) applications require: an organizational profile with mission and programs, a project proposal aligned with the funder's stated priorities, a project budget, and supporting attachments (IRS determination letter, board list, recent financials). Federal applicants additionally need a SAM.gov UEI and an active Grants.gov account.